| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AIMT | Aimmune Therapeutics, Inc. | Societe des Produits Nestle S.A. | 10% Owner | Oct 13, 2020 | Buy | $34.50 | 54,117,287 | 1,867,046,402 | 43,435,583 | Oct 15, 2020, 07:18 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Oxtoby Andrew | Chief Commercial Officer | Oct 10, 2020 | Option Exercise | $34.50 | 6,345 | 218,903 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Oxtoby Andrew | Chief Commercial Officer | Oct 13, 2020 | Option Exercise | $34.50 | 20,250 | 698,625 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Sheehy Douglas T. | See Remarks | Oct 10, 2020 | Option Exercise | $34.50 | 47,450 | 1,637,025 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Sheehy Douglas T. | See Remarks | Oct 13, 2020 | Option Exercise | $34.50 | 36,875 | 1,272,188 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Dallas Jayson Donald Alexander | President and CEO | Oct 13, 2020 | Option Exercise | $34.50 | 89,250 | 3,079,125 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Dallas Jayson Donald Alexander | President and CEO | Oct 10, 2020 | Option Exercise | $34.50 | 30,422 | 1,049,559 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | MCDADE MARK | Director | Oct 10, 2020 | Option Exercise | $34.50 | 26,852 | 926,394 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | MCDADE MARK | Director | Oct 13, 2020 | Option Exercise | $34.50 | 7,840 | 270,480 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Behar Gregory | Director | Oct 13, 2020 | Option Exercise | $34.50 | 7,840 | 270,480 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | HAUMANN BRETT K | Director | Oct 13, 2020 | Option Exercise | $34.50 | 13,313 | 459,299 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | HAUMANN BRETT K | Director | Oct 10, 2020 | Option Exercise | $34.50 | 6,250 | 215,625 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Seltzer Stacey Denenberg | Director | Oct 10, 2020 | Option Exercise | $34.50 | 10,221 | 352,625 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Seltzer Stacey Denenberg | Director | Oct 13, 2020 | Option Exercise | $34.50 | 7,840 | 270,480 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | BJERKHOLT ERIC | Chief Financial Officer | Oct 10, 2020 | Option Exercise | $34.50 | 27,805 | 959,273 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | BJERKHOLT ERIC | Chief Financial Officer | Oct 13, 2020 | Option Exercise | $34.50 | 23,905 | 824,723 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Iwicki Mark T | Director | Oct 13, 2020 | Option Exercise | $34.50 | 7,840 | 270,480 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | ENRIGHT PATRICK G | Director | Oct 10, 2020 | Option Exercise | $34.50 | 70,561 | 2,434,355 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | ENRIGHT PATRICK G | Director | Oct 10, 2020 | Option Exercise | $34.50 | 91,697 | 3,163,547 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | ENRIGHT PATRICK G | Director | Oct 13, 2020 | Option Exercise | $34.50 | 7,840 | 270,480 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Iwicki Mark T | Director | Oct 10, 2020 | Option Exercise | $34.50 | 39,567 | 1,365,062 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | ADELMAN DANIEL C MD | Chief Medical Officer | Oct 10, 2020 | Option Exercise | $34.50 | 41,464 | 1,430,508 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | ADELMAN DANIEL C MD | Chief Medical Officer | Oct 13, 2020 | Option Exercise | $34.50 | 22,343 | 770,834 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | FALBERG KATHRYN E | Director | Oct 10, 2020 | Option Exercise | $34.50 | 65,192 | 2,249,124 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | FALBERG KATHRYN E | Director | Oct 10, 2020 | Option Exercise | $34.50 | 69,894 | 2,411,343 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | FALBERG KATHRYN E | Director | Oct 13, 2020 | Option Exercise | $34.50 | 7,840 | 270,480 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | ADELMAN DANIEL C MD | Chief Medical Officer | Oct 02, 2020 | Option Exercise | $11.45 | 34,932 | 399,971 | 63,807 | Oct 05, 2020, 09:20 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Sheehy Douglas T. | See Remarks | Oct 05, 2020 | Option Exercise | $12.95 | 30,888 | 400,000 | 85,426 | Oct 05, 2020, 09:14 PM | |
| AIMT | Aimmune Therapeutics, Inc. | BJERKHOLT ERIC | Chief Financial Officer | Oct 05, 2020 | Option Exercise | $19.44 | 5,200 | 101,088 | 49,841 | Oct 05, 2020, 09:13 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Sheehy Douglas T. | See Remarks | Sep 15, 2020 | Option Exercise | $34.25 | 840 | 28,770 | 54,538 | Sep 16, 2020, 05:20 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Oxtoby Andrew | Chief Commercial Officer | Sep 15, 2020 | Option Exercise | $34.25 | 840 | 28,770 | 26,595 | Sep 16, 2020, 05:19 PM | |
| AIMT | Aimmune Therapeutics, Inc. | BJERKHOLT ERIC | Chief Financial Officer | Sep 15, 2020 | Option Exercise | $34.25 | 840 | 28,770 | 44,547 | Sep 16, 2020, 05:18 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Dallas Jayson Donald Alexander | President and CEO | Sep 15, 2020 | Option Exercise | $34.25 | 1,642 | 56,239 | 117,034 | Sep 16, 2020, 05:17 PM | |
| AIMT | Aimmune Therapeutics, Inc. | ADELMAN DANIEL C MD | Chief Medical Officer | Sep 15, 2020 | Option Exercise | $34.25 | 840 | 28,770 | 28,875 | Sep 16, 2020, 05:17 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Dallas Jayson Donald Alexander | President and CEO | Jun 22, 2020 | Option Exercise | $18.02 | 7,907 | 142,484 | 118,676 | Jun 26, 2020, 05:06 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Societe des Produits Nestle S.A. | 10% Owner | Feb 07, 2020 | Buy | $131.09 | 1,525,634 | 200,002,042 | 12,727,113 | Apr 24, 2020, 04:59 PM | |
| AIMT | Aimmune Therapeutics, Inc. | NESTLE SA | 10% Owner | Apr 22, 2020 | Option Exercise | $21.86 | 13,252,747 | 289,713,439 | 12,727,113 | Apr 24, 2020, 04:59 PM | |
| AIMT | Aimmune Therapeutics, Inc. | NESTLE SA | 10% Owner | Nov 28, 2018 | Buy | $30.27 | 3,237,529 | 98,000,004 | 11,727,113 | Apr 24, 2020, 04:45 PM | |
| AIMT | Aimmune Therapeutics, Inc. | NIMCO US, Inc. | 10% Owner | Feb 26, 2018 | Buy | $32.00 | 937,500 | 30,000,000 | 8,489,584 | Apr 24, 2020, 04:45 PM | |
| AIMT | Aimmune Therapeutics, Inc. | ENRIGHT PATRICK G | Director | Mar 17, 2020 | Buy | $11.50 | 8,787 | 101,051 | 54,348 | Mar 19, 2020, 05:03 PM | |
| AIMT | Aimmune Therapeutics, Inc. | ENRIGHT PATRICK G | Director | Mar 17, 2020 | Buy | $11.40 | 100,000 | 1,139,650 | 6,113,134 | Mar 19, 2020, 05:03 PM | |
| AIMT | Aimmune Therapeutics, Inc. | ENRIGHT PATRICK G | Director | Mar 18, 2020 | Buy | $11.06 | 16,213 | 179,345 | 70,561 | Mar 19, 2020, 05:03 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Oxtoby Andrew | Chief Commercial Officer | Mar 13, 2020 | Buy | $14.76 | 3,000 | 44,266 | 25,015 | Mar 17, 2020, 04:51 PM | |
| AIMT | Aimmune Therapeutics, Inc. | BJERKHOLT ERIC | Chief Financial Officer | Mar 12, 2020 | Buy | $15.10 | 1,000 | 15,100 | 42,967 | Mar 12, 2020, 09:13 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Dallas Jayson Donald Alexander | President and CEO | Mar 10, 2020 | Buy | $18.74 | 2,665 | 49,934 | 123,283 | Mar 10, 2020, 08:48 PM | |
| AIMT | Aimmune Therapeutics, Inc. | BJERKHOLT ERIC | Chief Financial Officer | Mar 09, 2020 | Buy | $18.97 | 1,000 | 18,970 | 41,967 | Mar 10, 2020, 08:47 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Oxtoby Andrew | Chief Commercial Officer | Jan 22, 2020 | Option Exercise | $33.23 | 1,235 | 41,039 | 10,765 | Mar 04, 2020, 09:49 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Dallas Jayson Donald Alexander | President and CEO | Mar 02, 2020 | Option Exercise | $23.81 | 3,081 | 73,359 | 120,618 | Mar 04, 2020, 09:42 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Sheehy Douglas T. | See Remarks | Mar 02, 2020 | Option Exercise | $23.81 | 3,960 | 94,288 | 52,958 | Mar 04, 2020, 09:38 PM | |
| AIMT | Aimmune Therapeutics, Inc. | BJERKHOLT ERIC | Chief Financial Officer | Mar 02, 2020 | Option Exercise | $23.81 | 1,982 | 47,191 | 40,967 | Mar 04, 2020, 09:36 PM | |
| AIMT | Aimmune Therapeutics, Inc. | ADELMAN DANIEL C MD | Chief Medical Officer | Mar 02, 2020 | Option Exercise | $23.81 | 1,872 | 44,572 | 27,295 | Mar 04, 2020, 09:34 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Sheehy Douglas T. | See Remarks | Jan 16, 2020 | Sale | $24.97 | 800 | 19,980 | 46,068 | Jan 21, 2020, 06:17 PM | |
| AIMT | Aimmune Therapeutics, Inc. | ADELMAN DANIEL C MD | Chief Medical Officer | Jan 02, 2020 | Sale | $27.32 | 40,000 | 1,092,638 | 41,250 | Jan 03, 2020, 08:41 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Sheehy Douglas T. | See Remarks | Dec 26, 2019 | Sale | $22.99 | 20,000 | 459,822 | 55,668 | Dec 30, 2019, 05:14 PM | |
| AIMT | Aimmune Therapeutics, Inc. | ADELMAN DANIEL C MD | Chief Medical Officer | Dec 09, 2019 | Sale | $20.74 | 40,000 | 829,716 | 41,250 | Dec 11, 2019, 05:50 PM | |
| AIMT | Aimmune Therapeutics, Inc. | BJERKHOLT ERIC | Chief Financial Officer | Sep 18, 2019 | Buy | $22.57 | 1,550 | 34,977 | 33,574 | Sep 20, 2019, 08:55 AM | |
| AIMT | Aimmune Therapeutics, Inc. | ENRIGHT PATRICK G | Director | Sep 17, 2019 | Option Exercise | $22.34 | 12,500 | 279,216 | 45,561 | Sep 19, 2019, 04:05 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Barrowcliffe Susan E. | General Manager, Europe | Nov 19, 2018 | Option Exercise | $16.53 | 80,000 | 1,322,480 | 49,375 | Nov 21, 2018, 04:05 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Dallas Jayson Donald Alexander | President and CEO | Nov 19, 2018 | Buy | $27.56 | 3,650 | 100,587 | 63,650 | Nov 19, 2018, 08:12 PM | |
| AIMT | Aimmune Therapeutics, Inc. | BJERKHOLT ERIC | Chief Financial Officer | Jun 13, 2018 | Buy | $30.41 | 1,600 | 48,663 | 19,485 | Jun 14, 2018, 04:08 PM | |
| AIMT | Aimmune Therapeutics, Inc. | DILLY STEPHEN GEORGE | President and CEO | Jun 11, 2018 | Sale | $16.93 | 58,914 | 997,323 | 344,765 | Jun 13, 2018, 04:06 PM | |
| AIMT | Aimmune Therapeutics, Inc. | DILLY STEPHEN GEORGE | President and CEO | Jun 06, 2018 | Option Exercise | $17.11 | 60,930 | 1,042,439 | 345,773 | Jun 08, 2018, 05:50 PM | |
| AIMT | Aimmune Therapeutics, Inc. | DILLY STEPHEN GEORGE | President and CEO | Jun 07, 2018 | Sale | $16.99 | 65,196 | 1,107,625 | 347,906 | Jun 08, 2018, 05:50 PM | |
| AIMT | Aimmune Therapeutics, Inc. | DILLY STEPHEN GEORGE | President and CEO | Jun 08, 2018 | Sale | $16.86 | 84,212 | 1,419,760 | 357,414 | Jun 08, 2018, 05:50 PM | |
| AIMT | Aimmune Therapeutics, Inc. | DILLY STEPHEN GEORGE | See Remarks | Jun 01, 2018 | Sale | $17.82 | 122,394 | 2,180,936 | 376,505 | Jun 05, 2018, 07:20 PM | |
| AIMT | Aimmune Therapeutics, Inc. | DILLY STEPHEN GEORGE | See Remarks | Jun 04, 2018 | Sale | $17.45 | 130,704 | 2,280,856 | 380,660 | Jun 05, 2018, 07:20 PM | |
| AIMT | Aimmune Therapeutics, Inc. | DILLY STEPHEN GEORGE | See Remarks | Jun 05, 2018 | Option Exercise | $17.43 | 77,650 | 1,353,168 | 354,133 | Jun 05, 2018, 07:20 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Sheehy Douglas T. | See Remarks | May 22, 2018 | Sale | $22.97 | 6,592 | 151,451 | 34,727 | May 24, 2018, 05:09 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Sheehy Douglas T. | See Remarks | Mar 05, 2018 | Sale | $26.51 | 7,046 | 186,815 | 34,375 | Mar 06, 2018, 08:40 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Rozenman Mary M. | See Remarks | Mar 01, 2018 | Option Exercise | $18.06 | 3,614 | 65,272 | 1,936 | Mar 05, 2018, 04:05 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Tammenoms Bakker Juliet | 10% Owner | Feb 22, 2018 | Buy | $32.00 | 9,375 | 300,000 | 16,651 | Feb 26, 2018, 04:25 PM | |
| AIMT | Aimmune Therapeutics, Inc. | ENRIGHT PATRICK G | Director | Feb 22, 2018 | Buy | $32.00 | 15,593 | 498,976 | 22,869 | Feb 26, 2018, 04:22 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Iwicki Mark T | Director | Feb 26, 2018 | Buy | $32.00 | 9,375 | 300,000 | 29,375 | Feb 26, 2018, 04:05 PM | |
| AIMT | Aimmune Therapeutics, Inc. | FALBERG KATHRYN E | Director | Feb 26, 2018 | Buy | $32.00 | 30,000 | 960,000 | 124,894 | Feb 26, 2018, 04:05 PM | |
| AIMT | Aimmune Therapeutics, Inc. | BJERKHOLT ERIC | Chief Financial Officer | Feb 26, 2018 | Buy | $32.00 | 3,125 | 100,000 | 8,125 | Feb 26, 2018, 04:05 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Sheehy Douglas T. | See Remarks | Feb 05, 2018 | Option Exercise | $24.41 | 3,296 | 80,455 | 1,648 | Feb 07, 2018, 04:06 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Rozenman Mary M. | See Remarks | Feb 01, 2018 | Sale | $19.19 | 13,184 | 253,009 | 6,721 | Feb 05, 2018, 04:05 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Sheehy Douglas T. | See Remarks | Jan 24, 2018 | Sale | $28.89 | 3,750 | 108,338 | 1,875 | Jan 26, 2018, 05:32 PM | |
| AIMT | Aimmune Therapeutics, Inc. | ADELMAN DANIEL C MD | Chief Medical Officer | Jan 12, 2018 | Sale | $25.72 | 53,568 | 1,378,037 | 26,784 | Jan 16, 2018, 06:05 PM | |
| AIMT | Aimmune Therapeutics, Inc. | ADELMAN DANIEL C MD | Chief Medical Officer | Jan 16, 2018 | Sale | $25.72 | 19,866 | 511,053 | 9,933 | Jan 16, 2018, 06:05 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Sheehy Douglas T. | See Remarks | Jan 04, 2018 | Sale | $25.14 | 3,296 | 82,861 | 1,648 | Jan 08, 2018, 04:07 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Rozenman Mary M. | See Remarks | Jan 02, 2018 | Sale | $20.07 | 13,182 | 264,508 | 6,720 | Jan 04, 2018, 04:05 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Barrowcliffe Susan E. | General Manager, Europe | Jan 02, 2018 | Sale | $20.08 | 150,000 | 3,011,840 | 75,000 | Jan 04, 2018, 12:00 AM | |
| AIMT | Aimmune Therapeutics, Inc. | ADELMAN DANIEL C MD | Chief Medical Officer | Dec 27, 2017 | Option Exercise | $25.72 | 6,566 | 168,910 | 3,283 | Dec 29, 2017, 05:26 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Rozenman Mary M. | See Remarks | Dec 26, 2017 | Sale | $20.95 | 150,020 | 3,142,766 | 75,139 | Dec 28, 2017, 05:45 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Sheehy Douglas T. | See Remarks | Dec 26, 2017 | Option Exercise | $29.53 | 3,750 | 110,756 | 1,875 | Dec 28, 2017, 05:43 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Sheehy Douglas T. | See Remarks | Dec 04, 2017 | Option Exercise | $25.80 | 3,812 | 98,369 | 1,906 | Dec 06, 2017, 04:05 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Sheehy Douglas T. | See Remarks | Nov 30, 2017 | Option Exercise | $28.31 | 7,500 | 212,362 | 3,750 | Dec 04, 2017, 04:05 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Sheehy Douglas T. | See Remarks | Nov 09, 2017 | Option Exercise | $22.97 | 3,810 | 87,535 | 1,905 | Nov 13, 2017, 05:26 PM | |
| AIMT | Aimmune Therapeutics, Inc. | DILLY STEPHEN GEORGE | See Remarks | Oct 23, 2017 | Sale | $33.55 | 100,000 | 3,354,538 | 339,840 | Oct 25, 2017, 04:05 PM | |
| AIMT | Aimmune Therapeutics, Inc. | ADELMAN DANIEL C MD | Chief Medical Officer | Oct 23, 2017 | Sale | $22.76 | 20,000 | 455,110 | 10,000 | Oct 25, 2017, 04:05 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Sheehy Douglas T. | See Remarks | Oct 23, 2017 | Sale | $24.62 | 94,850 | 2,335,343 | 34,300 | Oct 25, 2017, 04:05 PM | |
| AIMT | Aimmune Therapeutics, Inc. | DILLY STEPHEN GEORGE | President and CEO | Oct 16, 2017 | Sale | $26.24 | 1,154 | 30,279 | 415,308 | Oct 18, 2017, 07:59 PM | |
| AIMT | Aimmune Therapeutics, Inc. | DILLY STEPHEN GEORGE | President and CEO | Oct 05, 2017 | Sale | $26.24 | 14,689 | 385,495 | 420,509 | Oct 06, 2017, 06:02 PM | |
| AIMT | Aimmune Therapeutics, Inc. | DILLY STEPHEN GEORGE | President and CEO | Oct 06, 2017 | Sale | $26.31 | 4,047 | 106,468 | 416,462 | Oct 06, 2017, 06:02 PM | |
| AIMT | Aimmune Therapeutics, Inc. | DILLY STEPHEN GEORGE | President and CEO | Oct 04, 2017 | Sale | $26.23 | 80,110 | 2,101,353 | 465,308 | Oct 06, 2017, 06:02 PM | |
| AIMT | Aimmune Therapeutics, Inc. | ADELMAN DANIEL C MD | Chief Medical Officer | Sep 25, 2017 | Sale | $18.22 | 20,000 | 364,500 | 10,000 | Sep 27, 2017, 04:06 PM | |
| AIMT | Aimmune Therapeutics, Inc. | DILLY STEPHEN GEORGE | President and CEO | Sep 25, 2017 | Sale | $25.01 | 100,000 | 2,500,790 | 515,308 | Sep 27, 2017, 04:05 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Barrowcliffe Susan E. | General Manager, Europe | Sep 25, 2017 | Sale | $14.01 | 40,000 | 560,440 | 20,000 | Sep 27, 2017, 04:05 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Rozenman Mary M. | See Remarks | Sep 07, 2017 | Sale | $12.76 | 60,000 | 765,660 | 30,129 | Sep 11, 2017, 05:17 PM |
Menu